Immuron Limited (IMRN)

USD 1.92

(5.99%)

Net Income Summary of Immuron Limited

  • Immuron Limited's latest annual net income in 2024 was -6.93 Million AUD , down -83.2% from previous year.
  • Immuron Limited's latest quarterly net income in 2024 FY was -6.93 Million AUD , down -83.2% from previous quarter.
  • Immuron Limited reported an annual net income of -3.78 Million AUD in 2023, down -46.14% from previous year.
  • Immuron Limited reported an annual net income of -2.59 Million AUD in 2022, up 69.15% from previous year.
  • Immuron Limited reported a quarterly net income of -4.86 Million AUD for 2024 Q4, down 0.0% from previous quarter.
  • Immuron Limited reported a quarterly net income of -6.93 Million AUD for 2024 FY, down -83.2% from previous quarter.

Annual Net Income Chart of Immuron Limited (2024 - 1999)

Historical Annual Net Income of Immuron Limited (2024 - 1999)

Year Net Income Net Income Growth
2024 -6.93 Million AUD -83.2%
2023 -3.78 Million AUD -46.14%
2022 -2.59 Million AUD 69.15%
2021 -8.39 Million AUD -189.12%
2020 -2.9 Million AUD 37.46%
2019 -4.64 Million AUD -54.26%
2018 -3.01 Million AUD 55.75%
2017 -6.8 Million AUD 3.74%
2016 -7.06 Million AUD -162.6%
2015 -2.69 Million AUD -5.79%
2014 -2.54 Million AUD 28.1%
2013 -3.53 Million AUD -54.04%
2012 -2.29 Million AUD 11.47%
2011 -2.59 Million AUD -36.17%
2010 -1.9 Million AUD 17.78%
2009 -2.31 Million AUD 18.91%
2008 -2.85 Million AUD 12.89%
2007 -3.28 Million AUD 7.83%
2006 -3.55 Million AUD -166.98%
2005 -1.33 Million AUD -14.75%
2004 -1.16 Million AUD 0.0%
2003 - AUD 100.0%
2002 -1.69 Million AUD -9.37%
2001 -1.55 Million AUD 0.0%
2000 - AUD 0.0%
1999 - AUD 0.0%

Peer Net Income Comparison of Immuron Limited

Name Net Income Net Income Difference
NeuroSense Therapeutics Ltd. -10.1 Million USD 31.365%
Psyence Biomedical Ltd. -51.15 Million USD 86.44%
XOMA Corporation -40.83 Million USD 83.011%
Mesoblast Limited -87.95 Million USD 92.113%
Xeris Biopharma Holdings, Inc. -62.25 Million USD 88.857%
Aptorum Group Limited -2.82 Million USD -145.587%
Qualigen Therapeutics, Inc. -13.41 Million USD 48.298%
HilleVax, Inc. -123.56 Million USD 94.386%
Rocket Pharmaceuticals, Inc. -245.59 Million USD 97.175%
Corbus Pharmaceuticals Holdings, Inc. -44.6 Million USD 84.447%
Precision BioSciences, Inc. -61.31 Million USD 88.687%
Dyadic International, Inc. -6.79 Million USD -2.082%
Intensity Therapeutics, Inc. -10.53 Million USD 34.172%
IDEAYA Biosciences, Inc. -112.96 Million USD 93.859%
Eton Pharmaceuticals, Inc. -936 Thousand USD -641.128%
VYNE Therapeutics Inc. -28.45 Million USD 75.619%
EyePoint Pharmaceuticals, Inc. -70.79 Million USD 90.201%
Adaptive Biotechnologies Corporation -225.25 Million USD 96.92%
Tenaya Therapeutics, Inc. -124.08 Million USD 94.409%
IGM Biosciences, Inc. -246.41 Million USD 97.185%
Opthea Limited -220.24 Million USD 96.85%
Milestone Pharmaceuticals Inc. -59.68 Million USD 88.377%
Abeona Therapeutics Inc. -54.18 Million USD 87.198%
Tonix Pharmaceuticals Holding Corp. -116.65 Million USD 94.054%
Ligand Pharmaceuticals Incorporated 52.15 Million USD 113.301%
NextCure, Inc. -62.72 Million USD 88.94%
Inhibikase Therapeutics, Inc. -19.02 Million USD 63.545%
Ovid Therapeutics Inc. -52.33 Million USD 86.746%
CASI Pharmaceuticals, Inc. -26.93 Million USD 74.248%
Arcturus Therapeutics Holdings Inc. -29.72 Million USD 76.663%
Syros Pharmaceuticals, Inc. -164.57 Million USD 95.785%
Senti Biosciences, Inc. -92.91 Million USD 92.534%
Apollomics, Inc. -172.6 Million USD 95.981%
PureTech Health plc -65.69 Million USD 89.441%
Oncternal Therapeutics, Inc. -39.47 Million USD 82.429%
Barinthus Biotherapeutics plc -73.34 Million USD 90.542%
Kymera Therapeutics, Inc. -146.96 Million USD 95.28%
ChromaDex Corporation -4.93 Million USD -40.481%
Monopar Therapeutics Inc. -8.4 Million USD 17.439%
Akebia Therapeutics, Inc. -51.92 Million USD 86.64%
Sangamo Therapeutics, Inc. -257.83 Million USD 97.309%
Dermata Therapeutics, Inc. -7.79 Million USD 11.004%
Gritstone bio, Inc. -138.49 Million USD 94.991%
Virpax Pharmaceuticals, Inc. -15.18 Million USD 54.331%
Fate Therapeutics, Inc. -160.92 Million USD 95.689%
BioXcel Therapeutics, Inc. -179.05 Million USD 96.126%
Fortress Biotech, Inc. -60.63 Million USD 88.56%
Checkpoint Therapeutics, Inc. -51.84 Million USD 86.62%
Atossa Therapeutics, Inc. -30.09 Million USD 76.949%
Lyell Immunopharma, Inc. -234.63 Million USD 97.043%
Celcuity Inc. -63.77 Million USD 89.123%
ContextLogic Inc. -317 Million USD 97.812%
GH Research PLC -35.58 Million USD 80.507%
HOOKIPA Pharma Inc. -81.58 Million USD 91.497%
Cassava Sciences, Inc. -97.21 Million USD 92.864%
Cyclacel Pharmaceuticals, Inc. -22.55 Million USD 69.244%
ImmuCell Corporation -5.77 Million USD -20.129%
Amarin Corporation plc -59.11 Million USD 88.265%
TG Therapeutics, Inc. 12.67 Million USD 154.742%
X4 Pharmaceuticals, Inc. -101.16 Million USD 93.143%
Acelyrin, Inc. -381.64 Million USD 98.182%
BriaCell Therapeutics Corp. -4.79 Million USD -44.777%
Seer, Inc. -86.27 Million USD 91.96%
Novavax, Inc. -545.06 Million USD 98.727%
Phathom Pharmaceuticals, Inc. -201.59 Million USD 96.559%
Jazz Pharmaceuticals plc 414.83 Million USD 101.672%
AnaptysBio, Inc. -163.61 Million USD 95.76%
Aptevo Therapeutics Inc. -17.41 Million USD 60.158%
PMV Pharmaceuticals, Inc. -68.96 Million USD 89.941%
AbCellera Biologics Inc. -146.39 Million USD 95.262%
CorMedix Inc. -46.33 Million USD 85.03%
Cartesian Therapeutics, Inc. -219.71 Million USD 96.843%
Marker Therapeutics, Inc. -14.04 Million USD 50.612%
Regeneron Pharmaceuticals, Inc. 3.95 Billion USD 100.175%
Aptose Biosciences Inc. -51.2 Million USD 86.453%
ZyVersa Therapeutics, Inc. -98.29 Million USD 92.943%
Soligenix, Inc. -6.14 Million USD -12.966%
Century Therapeutics, Inc. -136.67 Million USD 94.924%
Arrowhead Pharmaceuticals, Inc. -205.27 Million USD 96.621%
TransCode Therapeutics, Inc. -18.54 Million USD 62.596%
Kura Oncology, Inc. -152.63 Million USD 95.455%
RAPT Therapeutics, Inc. -116.79 Million USD 94.061%
Ardelyx, Inc. -66.06 Million USD 89.5%
Ainos, Inc. -13.77 Million USD 49.625%
TScan Therapeutics, Inc. -89.21 Million USD 92.225%
Ocean Biomedical, Inc. 565.47 Thousand USD 1326.76%
Prothena Corporation plc -147.02 Million USD 95.282%
CytomX Therapeutics, Inc. -569 Thousand USD -1119.149%
Autolus Therapeutics plc -208.38 Million USD 96.671%
Mineralys Therapeutics, Inc. -71.89 Million USD 90.352%
Adaptimmune Therapeutics plc -113.87 Million USD 93.908%
Eterna Therapeutics Inc. -21.66 Million USD 67.985%
Celularity Inc. -196.29 Million USD 96.466%
Rallybio Corporation -74.56 Million USD 90.697%
GRI Bio, Inc. -13.03 Million USD 46.79%
Xenetic Biosciences, Inc. -4.13 Million USD -67.779%
Omeros Corporation -117.81 Million USD 94.112%
INmune Bio, Inc. -30 Million USD 76.883%
Heron Therapeutics, Inc. -110.55 Million USD 93.726%
SAB Biotherapeutics, Inc. -42.19 Million USD 83.559%
Pasithea Therapeutics Corp. -15.96 Million USD 56.54%
Entero Therapeutics, Inc. -15.79 Million USD 56.081%
Humacyte, Inc. -110.77 Million USD 93.738%
Atara Biotherapeutics, Inc. -276.12 Million USD 97.488%
Coherus BioSciences, Inc. -237.89 Million USD 97.084%
Immunocore Holdings plc -55.28 Million USD 87.453%
Cocrystal Pharma, Inc. -17.98 Million USD 61.427%
Verastem, Inc. -87.36 Million USD 92.06%
Pliant Therapeutics, Inc. -161.33 Million USD 95.7%
Histogen Inc. -10.62 Million USD 34.686%
Surrozen, Inc. -43.04 Million USD 83.883%
Blueprint Medicines Corporation -506.98 Million USD 98.632%
Organovo Holdings, Inc. -14.67 Million USD 52.717%
Lixte Biotechnology Holdings, Inc. -5.08 Million USD -36.366%
IO Biotech, Inc. -86.08 Million USD 91.942%
MEI Pharma, Inc. 17.77 Million USD 139.02%
GT Biopharma, Inc. -7.59 Million USD 8.688%
Centessa Pharmaceuticals plc -151.08 Million USD 95.409%
Hepion Pharmaceuticals, Inc. -48.92 Million USD 85.822%
Cabaletta Bio, Inc. -67.67 Million USD 89.75%
Summit Therapeutics Inc. -614.92 Million USD 98.872%
Alaunos Therapeutics, Inc. -35.14 Million USD 80.259%
Marinus Pharmaceuticals, Inc. -141.4 Million USD 95.094%
BioRestorative Therapies, Inc. -10.41 Million USD 33.412%
Turnstone Biologics Corp. -55.2 Million USD 87.433%
Pulmatrix, Inc. -14.12 Million USD 50.875%
Synaptogenix, Inc. -6.03 Million USD -14.879%
Tiziana Life Sciences Ltd -16.2 Million USD 57.2%
Aurinia Pharmaceuticals Inc. -78.02 Million USD 91.109%
Vigil Neuroscience, Inc. -82.63 Million USD 91.606%
Intellia Therapeutics, Inc. -481.19 Million USD 98.558%
Cytokinetics, Incorporated -526.24 Million USD 98.682%
Exelixis, Inc. 207.76 Million USD 103.339%
Nurix Therapeutics, Inc. -143.94 Million USD 95.181%
Apellis Pharmaceuticals, Inc. -528.62 Million USD 98.688%
Evogene Ltd. -23.87 Million USD 70.95%
Replimune Group, Inc. -215.79 Million USD 96.785%
PDS Biotechnology Corporation -42.94 Million USD 83.846%
Hoth Therapeutics, Inc. -7.84 Million USD 11.579%
Jasper Therapeutics, Inc. -64.46 Million USD 89.239%
ESSA Pharma Inc. -26.58 Million USD 73.904%
TNF Pharmaceuticals, Inc. -3.99 Million USD -73.426%
BioLineRx Ltd. -60.61 Million USD 88.556%
Avid Bioservices, Inc. -140.75 Million USD 95.072%
Insmed Incorporated -749.56 Million USD 99.075%
VistaGen Therapeutics, Inc. -29.36 Million USD 76.374%
Zentalis Pharmaceuticals, Inc. -292.19 Million USD 97.626%
Sagimet Biosciences Inc. -27.87 Million USD 75.115%
MediWound Ltd. -6.71 Million USD -3.29%
MiMedx Group, Inc. 67.43 Million USD 110.286%
OmniAb, Inc. -50.61 Million USD 86.296%
Alector, Inc. -130.39 Million USD 94.68%
Seres Therapeutics, Inc. -113.72 Million USD 93.9%
PTC Therapeutics, Inc. -626.6 Million USD 98.893%
Mereo BioPharma Group plc -29.46 Million USD 76.458%
Zai Lab Limited -334.62 Million USD 97.927%
Revance Therapeutics, Inc. -323.98 Million USD 97.859%
Syndax Pharmaceuticals, Inc. -209.36 Million USD 96.687%
Aura Biosciences, Inc. -76.4 Million USD 90.921%
Immunic, Inc. -93.61 Million USD 92.59%
Dyne Therapeutics, Inc. -235.93 Million USD 97.06%
Tarsus Pharmaceuticals, Inc. -135.89 Million USD 94.895%
Veracyte, Inc. -74.4 Million USD 90.677%
InMed Pharmaceuticals Inc. -7.67 Million USD 9.623%
FibroGen, Inc. -284.23 Million USD 97.559%
SeaStar Medical Holding Corporation -26.23 Million USD 73.555%
Allakos Inc. -185.7 Million USD 96.264%
scPharmaceuticals Inc. -54.81 Million USD 87.344%
Fulcrum Therapeutics, Inc. -97.33 Million USD 92.873%
Corcept Therapeutics Incorporated 106.14 Million USD 106.536%
Adial Pharmaceuticals, Inc. -7 Million USD 0.927%
NLS Pharmaceutics AG -12.17 Million USD 43.009%
Sonnet BioTherapeutics Holdings, Inc. -18.83 Million USD 63.165%
Amylyx Pharmaceuticals, Inc. 49.27 Million USD 114.079%
Precigen, Inc. -95.9 Million USD 92.767%
Fortrea Holdings Inc. -3.4 Million USD -104.028%
KalVista Pharmaceuticals, Inc. -126.64 Million USD 94.522%
Incyte Corporation 597.59 Million USD 101.161%
Alzamend Neuro, Inc. -9.94 Million USD 30.266%
Cara Therapeutics, Inc. -118.51 Million USD 94.147%
XBiotech Inc. -24.55 Million USD 71.752%
Aligos Therapeutics, Inc. -87.67 Million USD 92.088%
Jasper Therapeutics, Inc. -64.46 Million USD 89.239%
Reviva Pharmaceuticals Holdings, Inc. -24.33 Million USD 71.499%
CRISPR Therapeutics AG -153.61 Million USD 95.484%
Akero Therapeutics, Inc. -151.75 Million USD 95.429%
Eliem Therapeutics, Inc. -35.11 Million USD 80.247%
Lyra Therapeutics, Inc. -62.68 Million USD 88.933%
Foghorn Therapeutics Inc. -98.42 Million USD 92.952%
Agenus Inc. -245.76 Million USD 97.177%
Kiora Pharmaceuticals, Inc. -12.51 Million USD 44.566%
Y-mAbs Therapeutics, Inc. -21.42 Million USD 67.625%
Theravance Biopharma, Inc. -55.19 Million USD 87.431%
Ultragenyx Pharmaceutical Inc. -606.63 Million USD 98.856%
Metagenomi, Inc. Common Stock -68.25 Million USD 89.837%
Lexaria Bioscience Corp. -6.66 Million USD -4.082%
BioCryst Pharmaceuticals, Inc. -226.53 Million USD 96.938%
UroGen Pharma Ltd. -102.24 Million USD 93.215%
Gain Therapeutics, Inc. -22.26 Million USD 68.847%
Sutro Biopharma, Inc. -106.79 Million USD 93.504%
Creative Medical Technology Holdings, Inc. -5.28 Million USD -31.218%
Lisata Therapeutics, Inc. -20.84 Million USD 66.713%
Chemomab Therapeutics Ltd. -24.22 Million USD 71.36%
Stoke Therapeutics, Inc. -104.69 Million USD 93.374%
Chimerix, Inc. -82.09 Million USD 91.55%
Reneo Pharmaceuticals, Inc. -77.38 Million USD 91.036%
Outlook Therapeutics, Inc. -58.98 Million USD 88.239%
60 Degrees Pharmaceuticals, Inc. -3.76 Million USD -84.214%
Pluri Inc. -20.88 Million USD 66.79%
Cue Biopharma, Inc. -50.73 Million USD 86.327%
MeiraGTx Holdings plc -84.02 Million USD 91.744%
Aprea Therapeutics, Inc. -14.28 Million USD 51.445%
Cadrenal Therapeutics, Inc. Common Stock -8.35 Million USD 16.993%
Cidara Therapeutics, Inc. -22.93 Million USD 69.749%
ProMIS Neurosciences, Inc. -17.5 Million USD 60.374%
CalciMedica, Inc. -34.35 Million USD 79.809%
Scholar Rock Holding Corporation -165.78 Million USD 95.816%
Sana Biotechnology, Inc. -283.25 Million USD 97.551%
Elicio Therapeutics, Inc. -35.19 Million USD 80.29%
NLS Pharmaceutics AG -12.17 Million USD 43.009%
Adlai Nortye Ltd. American Depositary Shares -104.87 Million USD 93.385%
Nutriband Inc. -5.48 Million USD -26.464%
Protara Therapeutics, Inc. -40.42 Million USD 82.838%
Vor Biopharma Inc. -117.86 Million USD 94.114%
Roivant Sciences Ltd. 4.34 Billion USD 100.16%
ProKidney Corp. -35.46 Million USD 80.442%
Applied Therapeutics, Inc. -119.76 Million USD 94.208%
Daré Bioscience, Inc. -30.16 Million USD 77.001%
BridgeBio Pharma, Inc. -643.2 Million USD 98.921%
Titan Pharmaceuticals, Inc. -5.56 Million USD -24.564%
Bicycle Therapeutics plc -180.66 Million USD 96.16%
Tango Therapeutics, Inc. -101.74 Million USD 93.182%
Galectin Therapeutics Inc. -41.06 Million USD 83.108%
Revolution Medicines, Inc. Warrant -436.36 Million USD 98.41%
Atai Life Sciences N.V. -40.22 Million USD 82.754%
Renovaro Biosciences Inc. -80.65 Million USD 91.399%
Aerovate Therapeutics, Inc. -75.52 Million USD 90.815%
MediciNova, Inc. -8.57 Million USD 19.07%
Praxis Precision Medicines, Inc. -123.27 Million USD 94.373%
Cardio Diagnostics Holdings, Inc. -8.37 Million USD 17.189%
GeoVax Labs, Inc. -25.96 Million USD 73.285%
Protagonist Therapeutics, Inc. -78.95 Million USD 91.214%
Axsome Therapeutics, Inc. -239.23 Million USD 97.1%
Biomea Fusion, Inc. -117.25 Million USD 94.084%
RenovoRx, Inc. -10.23 Million USD 32.203%
Erasca, Inc. -125.04 Million USD 94.452%
Cullinan Oncology, Inc. -153.16 Million USD 95.471%
NRx Pharmaceuticals, Inc. -30.15 Million USD 76.992%
4D Molecular Therapeutics, Inc. -100.83 Million USD 93.121%
Kiniksa Pharmaceuticals, Ltd. 14.08 Million USD 149.254%
bluebird bio, Inc. -211.91 Million USD 96.727%
Ventyx Biosciences, Inc. -192.96 Million USD 96.405%
Pieris Pharmaceuticals, Inc. -24.54 Million USD 71.735%
Imunon, Inc. -19.51 Million USD 64.453%
BioMarin Pharmaceutical Inc. 167.64 Million USD 104.138%
BioAtla, Inc. -123.46 Million USD 94.381%
Allogene Therapeutics, Inc. -327.26 Million USD 97.88%
Larimar Therapeutics, Inc. -36.94 Million USD 81.226%
DBV Technologies S.A. -72.72 Million USD 90.462%
Fortress Biotech, Inc. -60.63 Million USD 88.56%
Avidity Biosciences, Inc. -212.22 Million USD 96.731%
Kezar Life Sciences, Inc. -101.87 Million USD 93.19%
aTyr Pharma, Inc. -50.38 Million USD 86.233%
Viridian Therapeutics, Inc. -237.73 Million USD 97.082%
EyeGate Pharmaceuticals, Inc. -8.09 Million USD 14.273%
Galecto, Inc. -38.34 Million USD 81.911%
Akari Therapeutics, Plc -10 Million USD 30.686%
Tevogen Bio Holdings Inc. -67.32 Thousand USD -10203.687%
Halozyme Therapeutics, Inc. 281.59 Million USD 102.463%
Lexicon Pharmaceuticals, Inc. -177.11 Million USD 96.083%
Entera Bio Ltd. -8.88 Million USD 21.96%
Travere Therapeutics, Inc. -111.39 Million USD 93.773%
Sensei Biotherapeutics, Inc. -34.1 Million USD 79.658%
Xencor, Inc. -126.08 Million USD 94.498%
Orchestra BioMed Holdings, Inc. -49.12 Million USD 85.878%
Spruce Biosciences, Inc. -47.91 Million USD 85.524%
Coeptis Therapeutics Holdings, Inc. -21.26 Million USD 67.381%
Vanda Pharmaceuticals Inc. 2.5 Million USD 376.483%
Lexaria Bioscience Corp. -6.66 Million USD -4.082%
Portage Biotech Inc. -75.33 Million USD 90.792%
Cardio Diagnostics Holdings, Inc. -8.37 Million USD 17.189%
Olema Pharmaceuticals, Inc. -96.65 Million USD 92.823%
OncoCyte Corporation -27.78 Million USD 75.03%
Processa Pharmaceuticals, Inc. -11.12 Million USD 37.626%
Purple Biotech Ltd. -19.88 Million USD 65.106%
CollPlant Biotechnologies Ltd. -7.01 Million USD 1.169%
Onconetix, Inc. -37.4 Million USD 81.457%
MacroGenics, Inc. -9.05 Million USD 23.416%
Tharimmune, Inc. -9.31 Million USD 25.562%
Genprex, Inc. -30.86 Million USD 77.522%
Apogee Therapeutics, Inc. -83.98 Million USD 91.74%
Neumora Therapeutics, Inc. Common Stock -235.92 Million USD 97.06%
Ocuphire Pharma, Inc. -9.98 Million USD 30.533%
Prime Medicine, Inc. -198.13 Million USD 96.499%
Aditxt, Inc. -32.38 Million USD 78.577%
XTL Biopharmaceuticals Ltd. -1.78 Million USD -289.279%
Virios Therapeutics, Inc. -5.29 Million USD -30.984%
OKYO Pharma Limited -16.82 Thousand USD -41128.929%
Savara Inc. -54.69 Million USD 87.318%
Curis, Inc. -47.41 Million USD 85.369%
Carmell Therapeutics Corporation -15.44 Million USD 55.086%
Adagene Inc. -18.94 Million USD 63.386%
Achieve Life Sciences, Inc. -29.81 Million USD 76.733%
BeiGene, Ltd. -881.7 Million USD 99.213%
Inhibrx Biosciences, Inc. -241.36 Million USD 97.126%
GlycoMimetics, Inc. -36.89 Million USD 81.2%
Maravai LifeSciences Holdings, Inc. -119.02 Million USD 94.172%
Protagenic Therapeutics, Inc. -5 Million USD -38.725%
SciSparc Ltd. -5.12 Million USD -35.435%
Protagenic Therapeutics, Inc. -5 Million USD -38.725%
Vincerx Pharma, Inc. -40.15 Million USD 82.725%
Revelation Biosciences, Inc. -120.25 Thousand USD -5668.587%
Minerva Neurosciences, Inc. -30 Million USD 76.881%
Fresh Tracks Therapeutics, Inc. -5.69 Million USD -21.829%
Arcutis Biotherapeutics, Inc. -262.14 Million USD 97.354%
Acrivon Therapeutics, Inc. Common Stock -60.38 Million USD 88.513%
Alnylam Pharmaceuticals, Inc. -440.24 Million USD 98.424%
ADMA Biologics, Inc. -28.23 Million USD 75.435%
Rigel Pharmaceuticals, Inc. -25.09 Million USD 72.353%
Clene Inc. -49.5 Million USD 85.987%
Celldex Therapeutics, Inc. -141.42 Million USD 95.095%
Cogent Biosciences, Inc. -192.41 Million USD 96.395%
Boundless Bio, Inc. Common Stock -49.43 Million USD 85.967%
Recursion Pharmaceuticals, Inc. -328.06 Million USD 97.885%
Adicet Bio, Inc. -142.65 Million USD 95.137%
Contineum Therapeutics, Inc. Class A Common Stock 22.72 Million USD 130.532%
Absci Corporation -110.56 Million USD 93.726%
Estrella Immunopharma, Inc. -7.31 Million USD 5.126%
Quantum-Si incorporated -95.96 Million USD 92.771%
Acurx Pharmaceuticals, Inc. -14.57 Million USD 52.414%
Voyager Therapeutics, Inc. 132.33 Million USD 105.242%
Surrozen, Inc. -43.04 Million USD 83.883%
Generation Bio Co. -126.61 Million USD 94.521%
Astria Therapeutics, Inc. -72.89 Million USD 90.483%
Caribou Biosciences, Inc. -102.07 Million USD 93.204%
Black Diamond Therapeutics, Inc. -82.44 Million USD 91.586%
Janux Therapeutics, Inc. -58.29 Million USD 88.1%
Invivyd, Inc. -198.64 Million USD 96.508%
Cingulate Inc. -23.53 Million USD 70.525%
Relay Therapeutics, Inc. -341.97 Million USD 97.971%
Quoin Pharmaceuticals, Ltd. -8.68 Million USD 20.142%
Tenax Therapeutics, Inc. -7.71 Million USD 10.034%
Spero Therapeutics, Inc. 22.8 Million USD 130.417%
Jaguar Health, Inc. -41.3 Million USD 83.203%
Artelo Biosciences, Inc. -9.87 Million USD 29.745%
2seventy bio, Inc. -217.57 Million USD 96.812%
Clearside Biomedical, Inc. -32.48 Million USD 78.646%
Terns Pharmaceuticals, Inc. -90.21 Million USD 92.31%
ACADIA Pharmaceuticals Inc. -61.28 Million USD 88.681%
Capricor Therapeutics, Inc. -22.28 Million USD 68.875%
Citius Pharmaceuticals, Inc. -32.54 Million USD 78.684%
Relmada Therapeutics, Inc. -98.79 Million USD 92.978%
Kronos Bio, Inc. -112.67 Million USD 93.843%
Innoviva, Inc. 179.72 Million USD 103.86%
Bolt Biotherapeutics, Inc. -69.19 Million USD 89.975%
Entrada Therapeutics, Inc. -6.68 Million USD -3.769%
ALX Oncology Holdings Inc. -160.8 Million USD 95.686%
Vir Biotechnology, Inc. -615.06 Million USD 98.872%
Evaxion Biotech A/S -22.12 Million USD 68.647%
Ocular Therapeutix, Inc. -80.73 Million USD 91.408%
Verve Therapeutics, Inc. -200.06 Million USD 96.533%
Tyra Biosciences, Inc. -69.13 Million USD 89.966%
Galmed Pharmaceuticals Ltd. -6.91 Million USD -0.361%
Unity Biotechnology, Inc. -39.86 Million USD 82.597%
Connect Biopharma Holdings Limited -59.5 Million USD 88.342%
Clearmind Medicine Inc. -11.95 Million USD 41.975%
AlloVir, Inc. -190.41 Million USD 96.357%
ORIC Pharmaceuticals, Inc. -100.69 Million USD 93.111%
Catalyst Pharmaceuticals, Inc. 71.41 Million USD 109.714%
CERo Therapeutics Holdings, Inc. -2536.23 USD -273414.508%
Viking Therapeutics, Inc. -85.89 Million USD 91.924%
Keros Therapeutics, Inc. -152.99 Million USD 95.466%
SELLAS Life Sciences Group, Inc. -37.34 Million USD 81.422%
Crinetics Pharmaceuticals, Inc. -214.52 Million USD 96.766%
ImmunityBio, Inc. -583.19 Million USD 98.811%
Korro Bio, Inc. -81.17 Million USD 91.454%
C4 Therapeutics, Inc. -132.49 Million USD 94.764%
Kineta, Inc. -14.09 Million USD 50.798%
Lantern Pharma Inc. -15.96 Million USD 56.54%
BioVie Inc. -32.12 Million USD 78.403%
Codexis, Inc. -76.24 Million USD 90.901%
Celularity Inc. -196.29 Million USD 96.466%
Eledon Pharmaceuticals, Inc. -40.32 Million USD 82.798%
Virax Biolabs Group Limited -6.73 Million USD -3.021%
Kodiak Sciences Inc. -260.49 Million USD 97.337%
Cibus, Inc. -267.62 Million USD 97.408%
Annexon, Inc. -134.23 Million USD 94.832%
Assembly Biosciences, Inc. -61.22 Million USD 88.67%
Moderna, Inc. -4.71 Billion USD 99.853%
Ionis Pharmaceuticals, Inc. -366.28 Million USD 98.106%
Adverum Biotechnologies, Inc. -117.16 Million USD 94.079%
Avalo Therapeutics, Inc. -31.54 Million USD 78.009%
Immix Biopharma, Inc. -15.42 Million USD 55.031%
Eyenovia, Inc. -27.26 Million USD 74.554%
Puma Biotechnology, Inc. 21.59 Million USD 132.129%
Monte Rosa Therapeutics, Inc. -135.35 Million USD 94.875%
Wave Life Sciences Ltd. -57.51 Million USD 87.938%
Conduit Pharmaceuticals Inc. -535 Thousand USD -1196.627%
Xilio Therapeutics, Inc. -76.4 Million USD 90.921%
Alkermes plc 355.75 Million USD 101.95%
Arcellx, Inc. -70.69 Million USD 90.187%
Moolec Science SA -51.78 Million USD 86.605%
Cardiff Oncology, Inc. -41.44 Million USD 83.261%
LAVA Therapeutics N.V. -41.97 Million USD 83.473%
Enanta Pharmaceuticals, Inc. -133.81 Million USD 94.816%
Regulus Therapeutics Inc. -30.03 Million USD 76.905%
Atea Pharmaceuticals, Inc. -135.95 Million USD 94.898%
Compass Therapeutics, Inc. -42.49 Million USD 83.675%
Greenwich LifeSciences, Inc. -8.89 Million USD 21.985%
Humacyte, Inc. -110.77 Million USD 93.738%
Acumen Pharmaceuticals, Inc. -52.37 Million USD 86.754%
Geron Corporation -184.12 Million USD 96.233%
Verrica Pharmaceuticals Inc. -66.99 Million USD 89.646%
Avenue Therapeutics, Inc. -10.37 Million USD 33.151%
Royalty Pharma plc 1.13 Billion USD 100.611%
TFF Pharmaceuticals, Inc. -21.24 Million USD 67.345%
Notable Labs, Ltd. -11.26 Million USD 38.415%
Mersana Therapeutics, Inc. -171.67 Million USD 95.959%
Structure Therapeutics Inc. -89.62 Million USD 92.26%
IN8bio, Inc. -30 Million USD 76.882%
89bio, Inc. -142.18 Million USD 95.121%
DiaMedica Therapeutics Inc. -19.38 Million USD 64.207%
Vera Therapeutics, Inc. -95.99 Million USD 92.773%
Acasti Pharma Inc. -12.85 Million USD 46.028%
Genelux Corporation -28.29 Million USD 75.485%
Trevi Therapeutics, Inc. -29.06 Million USD 76.133%
Liquidia Corporation -78.5 Million USD 91.163%
Mustang Bio, Inc. -51.6 Million USD 86.557%
Immunovant, Inc. -259.33 Million USD 97.325%
Vericel Corporation -3.18 Million USD -118.006%
Quantum-Si incorporated -95.96 Million USD 92.771%
Arbutus Biopharma Corporation -72.84 Million USD 90.478%
XOMA Corporation -40.83 Million USD 83.011%
ARS Pharmaceuticals, Inc. -54.36 Million USD 87.24%
MiNK Therapeutics, Inc. -22.45 Million USD 69.111%
Pasithea Therapeutics Corp. -15.96 Million USD 56.54%
Alpha Tau Medical Ltd. -29.15 Million USD 76.208%
Vaxcyte, Inc. -402.26 Million USD 98.276%
Xenon Pharmaceuticals Inc. -182.39 Million USD 96.197%
Estrella Immunopharma, Inc. -7.31 Million USD 5.126%
NeuroBo Pharmaceuticals, Inc. -12.47 Million USD 44.371%
Tempest Therapeutics, Inc. -29.49 Million USD 76.478%
Sol-Gel Technologies Ltd. -27.23 Million USD 74.532%
Rhythm Pharmaceuticals, Inc. -184.67 Million USD 96.244%
Soleno Therapeutics, Inc. -38.98 Million USD 82.207%
Enlivex Therapeutics Ltd. -29.06 Million USD 76.135%
PepGen Inc. -78.62 Million USD 91.177%
Moleculin Biotech, Inc. -29.76 Million USD 76.697%
United Therapeutics Corporation 984.8 Million USD 100.704%
Solid Biosciences Inc. -96.01 Million USD 92.775%
BriaCell Therapeutics Corp. -4.79 Million USD -44.777%
Conduit Pharmaceuticals Inc. -535 Thousand USD -1196.627%
Immuneering Corporation -53.47 Million USD 87.027%
Lixte Biotechnology Holdings, Inc. -5.08 Million USD -36.366%
Silo Pharma, Inc. -3.7 Million USD -87.451%
Telomir Pharmaceuticals, Inc. Common Stock -13.07 Million USD 46.932%
Belite Bio, Inc -31.63 Million USD 78.07%
Pharming Group N.V. -10.54 Million USD 34.234%
Reviva Pharmaceuticals Holdings, Inc. -24.33 Million USD 71.499%
Bionomics Limited -15.49 Billion USD 99.955%
Pyxis Oncology, Inc. -73.79 Million USD 90.599%
uniQure N.V. -308.47 Million USD 97.751%
Windtree Therapeutics, Inc. -20.29 Million USD 65.813%
GeoVax Labs, Inc. -25.96 Million USD 73.285%
Poseida Therapeutics, Inc. -123.43 Million USD 94.38%
Altimmune, Inc. -88.44 Million USD 92.157%
Anebulo Pharmaceuticals, Inc. -8.2 Million USD 15.421%
Alpha Tau Medical Ltd. -29.15 Million USD 76.208%
Peak Bio, Inc. -1259.26 USD -550775.673%
SeaStar Medical Holding Corporation -26.23 Million USD 73.555%
FibroBiologics, Inc. Common Stock -16.48 Million USD 57.92%
Benitec Biopharma Inc. -21.75 Million USD 68.107%
Zura Bio Limited -60.36 Million USD 88.507%
Amicus Therapeutics, Inc. -151.58 Million USD 95.424%
Salarius Pharmaceuticals, Inc. -12.54 Thousand USD -55206.772%
Compugen Ltd. -18.75 Million USD 63.011%
Elevai Labs, Inc. Common Stock -4.3 Million USD -61.268%
argenx SE -295.05 Million USD 97.649%
Zevra Therapeutics, Inc. -46.04 Million USD 84.936%
Nuvectis Pharma, Inc. -22.26 Million USD 68.837%
Spyre Therapeutics, Inc. -338.79 Million USD 97.952%
NKGen Biotech, Inc. Common Stock -82.95 Million USD 91.638%
Madrigal Pharmaceuticals, Inc. -373.63 Million USD 98.143%
PolyPid Ltd. -23.86 Million USD 70.933%
Aileron Therapeutics, Inc. -15.73 Million USD 55.905%
Plus Therapeutics, Inc. -13.31 Million USD 47.905%
Forte Biosciences, Inc. -31.47 Million USD 77.961%
Dianthus Therapeutics, Inc. -43.55 Million USD 84.073%
Instil Bio, Inc. -156.08 Million USD 95.556%
Elevation Oncology, Inc. -45.7 Million USD 84.822%
Immunome, Inc. -106.8 Million USD 93.505%
Verona Pharma plc -54.36 Million USD 87.241%
Enveric Biosciences, Inc. -17.29 Thousand USD -40017.195%
enGene Holdings Inc. Warrants -99.91 Million USD 93.057%
Shattuck Labs, Inc. -87.29 Million USD 92.054%
LENZ Therapeutics, Inc. -124.65 Million USD 94.435%
Design Therapeutics, Inc. -66.86 Million USD 89.625%
Leap Therapeutics, Inc. -81.41 Million USD 91.479%
Seelos Therapeutics, Inc. -37.88 Million USD 81.688%
Achilles Therapeutics plc -69.66 Million USD 90.042%
Fractyl Health, Inc. Common Stock -77.09 Million USD 91.002%
Rani Therapeutics Holdings, Inc. -33.97 Million USD 79.579%
MoonLake Immunotherapeutics -36 Million USD 80.735%
Beam Therapeutics Inc. -132.52 Million USD 94.766%
Moolec Science SA -51.78 Million USD 86.605%
Longboard Pharmaceuticals, Inc. -54.42 Million USD 87.253%
AEON Biopharma, Inc. -52.55 Million USD 86.801%
Aadi Bioscience, Inc. -65.76 Million USD 89.452%
Enliven Therapeutics, Inc. -71.58 Million USD 90.309%
Iovance Biotherapeutics, Inc. -444.03 Million USD 98.438%
Taysha Gene Therapies, Inc. -111.56 Million USD 93.782%
Inovio Pharmaceuticals, Inc. -135.11 Million USD 94.866%
Athira Pharma, Inc. -117.67 Million USD 94.105%
HCW Biologics Inc. -24.99 Million USD 72.246%
XOMA Corporation -40.83 Million USD 83.011%
NeurAxis, Inc. -14.62 Million USD 52.573%
Lumos Pharma, Inc. -34.03 Million USD 79.618%
enGene Holdings Inc. Common Stock -99.91 Million USD 93.057%
180 Life Sciences Corp. -19.93 Million USD 65.202%
Nektar Therapeutics -276.05 Million USD 97.487%
NKGen Biotech, Inc. Warrants -82.95 Million USD 91.638%
Opiant Pharmaceuticals, Inc. 3 Million USD 330.556%
Arvinas, Inc. -367.3 Million USD 98.111%
CERo Therapeutics Holdings, Inc. -2536.23 USD -273414.508%
Palisade Bio, Inc. -12.3 Million USD 43.602%
Nutriband Inc. -5.48 Million USD -26.464%
Tevogen Bio Holdings Inc. -67.32 Thousand USD -10203.687%
CG Oncology, Inc. Common stock -48.6 Million USD 85.728%
Tourmaline Bio, Inc. -42.12 Million USD 83.532%
Merus N.V. -154.93 Million USD 95.523%
Omega Therapeutics, Inc. -97.42 Million USD 92.88%
Neurogene Inc. -36.31 Million USD 80.899%
Mirum Pharmaceuticals, Inc. -163.41 Million USD 95.755%
Kintara Therapeutics, Inc. -8.5 Million USD 18.398%
CervoMed Inc. -2.17 Million USD -219.4%
CARGO Therapeutics, Inc. Common Stock -98.14 Million USD 92.932%
Sesen Bio, Inc. -19.88 Million USD 65.113%
Quince Therapeutics, Inc. -31.38 Million USD 77.897%
Rezolute, Inc. -68.45 Million USD 89.867%
Clene Inc. -49.5 Million USD 85.987%
Indaptus Therapeutics, Inc. -15.42 Million USD 55.023%
BeyondSpring Inc. -21.02 Million USD 67.008%
Synlogic, Inc. -57.28 Million USD 87.89%
Allarity Therapeutics, Inc. -11.9 Million USD 41.711%
Phio Pharmaceuticals Corp. -10.82 Million USD 35.923%
Peak Bio, Inc. -1259.26 USD -550775.673%
Werewolf Therapeutics, Inc. -37.36 Million USD 81.436%
Krystal Biotech, Inc. 10.93 Million USD 163.456%
Karyopharm Therapeutics Inc. -143.09 Million USD 95.152%
SpringWorks Therapeutics, Inc. -325.1 Million USD 97.866%
Lipella Pharmaceuticals Inc. -4.61 Million USD -50.184%
MannKind Corporation -11.93 Million USD 41.892%
Ikena Oncology, Inc. -68.16 Million USD 89.823%
Cyclerion Therapeutics, Inc. -21.01 Million USD 66.99%
Gyre Therapeutics, Inc. -92.93 Million USD 92.536%
Gossamer Bio, Inc. -179.81 Million USD 96.142%
CohBar, Inc. -11.96 Million USD 42.009%
Cognition Therapeutics, Inc. -25.78 Million USD 73.1%
NRx Pharmaceuticals, Inc. -30.15 Million USD 76.992%
Legend Biotech Corporation -518.25 Million USD 98.661%
Mural Oncology plc -207.44 Million USD 96.656%
Disc Medicine, Inc. -76.42 Million USD 90.924%
Champions Oncology, Inc. -7.27 Million USD 4.66%
REGENXBIO Inc. -263.49 Million USD 97.367%
Ensysce Biosciences, Inc. -10.61 Million USD 34.638%
Anavex Life Sciences Corp. -47.5 Million USD 85.397%
Cellectar Biosciences, Inc. -37.98 Million USD 81.737%
Edgewise Therapeutics, Inc. -100.16 Million USD 93.074%
Vaxart, Inc. -82.46 Million USD 91.588%
PharmaCyte Biotech, Inc. 333.76 Thousand USD 2178.408%
Aldeyra Therapeutics, Inc. -37.54 Million USD 81.522%
Cellectis S.A. -101.05 Million USD 93.136%
Longeveron Inc. -21.41 Million USD 67.604%
Repare Therapeutics Inc. -93.79 Million USD 92.604%
Sarepta Therapeutics, Inc. -535.97 Million USD 98.706%
Inozyme Pharma, Inc. -71.16 Million USD 90.253%
Revolution Medicines, Inc. -436.36 Million USD 98.41%
Nymox Pharmaceutical Corporation -6.57 Million USD -5.569%
Third Harmonic Bio, Inc. -30.82 Million USD 77.495%
ArriVent BioPharma, Inc. Common Stock -69.33 Million USD 89.995%
AN2 Therapeutics, Inc. -64.73 Million USD 89.284%
Anixa Biosciences, Inc. -9.81 Million USD 29.294%
Vertex Pharmaceuticals Incorporated 3.61 Billion USD 100.192%
Denali Therapeutics Inc. -145.22 Million USD 95.223%
Revelation Biosciences, Inc. -120.25 Thousand USD -5668.587%
Veru Inc. -93.15 Million USD 92.553%
Corvus Pharmaceuticals, Inc. -27.02 Million USD 74.335%
Cingulate Inc. -23.53 Million USD 70.525%
Passage Bio, Inc. -102.06 Million USD 93.203%
Context Therapeutics Inc. -23.96 Million USD 71.053%
Exicure, Inc. -16.91 Million USD 58.987%
Day One Biopharmaceuticals, Inc. -188.91 Million USD 96.328%
Oramed Pharmaceuticals Inc. -37.76 Million USD 81.631%
Scinai Immunotherapeutics Ltd. -6.5 Million USD -6.602%
Nuvalent, Inc. -126.21 Million USD 94.504%
ABVC BioPharma, Inc. -10.51 Million USD 34.032%
Carisma Therapeutics, Inc. -86.87 Million USD 92.015%
Unicycive Therapeutics, Inc. -30.54 Million USD 77.289%
OmniAb, Inc. -50.61 Million USD 86.296%
Anew Medical, Inc. 1.34 Million USD 615.328%
Fennec Pharmaceuticals Inc. -16.04 Million USD 56.766%
Lipocine Inc. -16.35 Million USD 57.578%
Lexeo Therapeutics, Inc. Common Stock -66.39 Million USD 89.552%
Nautilus Biotechnology, Inc. -63.67 Million USD 89.106%
SAB Biotherapeutics, Inc. -42.19 Million USD 83.559%
G1 Therapeutics, Inc. -47.96 Million USD 85.538%
Bellerophon Therapeutics, Inc. -19.83 Million USD 65.02%
Sage Therapeutics, Inc. -541.48 Million USD 98.719%
Ocugen, Inc. -63.07 Million USD 89.003%
Mind Medicine (MindMed) Inc. -95.73 Million USD 92.754%
Q32 Bio Inc. -112.96 Million USD 93.859%
Brainstorm Cell Therapeutics Inc. -17.19 Million USD 59.65%
Alumis Inc. Common Stock -154.99 Million USD 95.524%
Equillium, Inc. -13.33 Million USD 47.979%
Kyverna Therapeutics, Inc. -60.36 Million USD 88.509%
Coya Therapeutics, Inc. -7.98 Million USD 13.156%
CNS Pharmaceuticals, Inc. -18.85 Million USD 63.202%
Dominari Holdings Inc. -22.88 Million USD 69.684%
Edesa Biotech, Inc. -8.37 Million USD 17.165%
vTv Therapeutics Inc. -20.25 Million USD 65.743%
Bio-Techne Corporation 168.1 Million USD 104.127%
Agios Pharmaceuticals, Inc. -352.08 Million USD 98.03%
Harmony Biosciences Holdings, Inc. 128.85 Million USD 105.384%
Prelude Therapeutics Incorporated -121.83 Million USD 94.306%
Candel Therapeutics, Inc. -37.93 Million USD 81.715%
iTeos Therapeutics, Inc. -112.64 Million USD 93.842%
Nkarta, Inc. -117.5 Million USD 94.096%
BioCardia, Inc. -11.57 Million USD 40.049%
Iterum Therapeutics plc -38.37 Million USD 81.921%